Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
TuHURA Biosciences, Inc./NV See All Filings	D	2025-11-10 16:07:26 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001498382 Filed Document 0001498382-25-000004 Exclusions or Exemptions 506b Accepted Date 2025-11-10 16:07:26 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Equity
TuHURA Biosciences, Inc./NV See All Filings	D	2025-06-13 06:15:06 UTC
Amount To Be Raised $12,612,120 Associated Brokers / Dealers Paulson Investment Company, LLC and Brookline Capital Markets, a division of Arcadia Securities, LLC CIK Number 0001498382 Filed Document 0000950123-25-006026 Exclusions or Exemptions 506b Accepted Date 2025-06-13 06:15:06 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Equity
Kintara Therapeutics, Inc. See All Filings	D	2020-08-28 10:50:08 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers Aegis Capital Corp. CIK Number 0001498382 Filed Document 0000905718-20-000907 Exclusions or Exemptions 506b Accepted Date 2020-08-28 10:50:08 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Kintara Therapeutics, Inc. See All Filings	D	2020-08-27 15:36:52 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers Aegis Capital Corp. CIK Number 0001498382 Filed Document 0000905718-20-000905 Exclusions or Exemptions 506b Accepted Date 2020-08-27 15:36:52 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
DelMar Pharmaceuticals, Inc. See All Filings	D	2016-05-10 00:00:00 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers Newport Coast Scurities Inc and Aegis Capital Corp CIK Number 0001498382 Filed Document 0001013762-16-001563 Exclusions or Exemptions 506b Accepted Date 2016-05-10 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business BRITISH COLUMBIA, CANADA Revenue or Assets $No Revenues Type of Security Equity